Lilly’s New Weight-Loss Pill Foundayo Gets Off to a Slow Start
Lilly’s new weight-loss pill started slow, far behind Novo’s, but it’s too early to tell which drug will win.
Already have an account? Sign in.
Lilly’s new weight-loss pill started slow, far behind Novo’s, but it’s too early to tell which drug will win.
Berkshire Q2 profit jumps 16% to $13B, beating forecasts. CEO Abel cuts cash pile, buys $10B Alphabet stock & accelerates $7.8B buybacks.
Revenue hit $174.9M (down 27%), net loss $1.60/share from Bitcoin mark-to-market losses.
Ashland is exploring a potential sale after takeover interest from PE firms like Advent, Apollo & Carlyle, following activist pressure from Ancora.